Discovery of a Key Gene That Influences Liver's Energy Storage Strategy

A groundbreaking study uncovers how the PPP1R3B gene acts as a metabolic switch in the liver, influencing whether energy is stored as sugar or fat—a discovery with potential implications for managing metabolic diseases like diabetes and fatty liver.
A recent study published in Science Advances has shed light on the crucial role of a specific gene in determining how the liver manages energy storage—a process vital for overall health and the regulation of metabolic conditions such as type 2 diabetes. Led by Dr. Kate Townsend Creasy from the University of Pennsylvania School of Nursing, the research zeroed in on the gene PPP1R3B. This gene functions as a regulatory switch, guiding the liver to store energy either as glycogen, a form of sugar, or as triglycerides, a type of fat.
The study found that increased activity of PPP1R3B promotes the storage of energy primarily as glycogen. Conversely, when the gene's activity diminishes, the liver tends to store more energy as fat. This balance between glycogen and fat storage is critical because it influences blood sugar and lipid levels, impacting metabolic health.
Genomic studies in humans have also linked mutations in PPP1R3B to metabolic disorders like type 2 diabetes and fatty liver disease, though the precise mechanisms remained unclear until now. Dr. Creasy describes PPP1R3B as a "metabolic switch"—directing whether the liver rapidly stores energy for immediate use or for longer-term storage as fat. The research demonstrated that genetic manipulations of the gene in mice and cell models affected how efficiently they used glucose and fat for energy.
Understanding this gene’s function opens new avenues for personalized nutrition and therapeutic strategies targeting metabolic diseases, based on an individual’s genetic makeup.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Breakthrough in COVID-19 Recovery: High-Dose Vitamin B3 Targeted at Gut Microbiome Accelerates Healing
A groundbreaking clinical trial demonstrates that targeted high-dose vitamin B3 in the gut accelerates recovery in COVID-19 patients by modulating the microbiome and boosting metabolic processes.
Restoring Muscle Stem Cell Function to Combat Age-Related Frailty
New research shows that Prostaglandin E2 can rejuvenate aged muscle stem cells, improving muscle regeneration and strength in older individuals, offering promising strategies against age-related frailty.
Study Shows Proven Cost-Effective Supply of Generic Medications Through Nonprofit Models
A new study demonstrates that nonprofit healthcare models like CivicaScript can reliably provide essential generic medicines at major savings for patients and insurers, highlighting a path toward more affordable drug access.
Cocoa Extract Supplement Lowers Inflammation Markers and Supports Healthy Aging, Study Shows
New research indicates that cocoa extract supplements can lower inflammation markers associated with aging and cardiovascular risk, supporting the benefits of plant-based diets for healthy aging.



